Meeting
2011 Breast Cancer Symposium
Utilization of pegfilgrastim in adjuvant chemotherapy regimens for breast cancer in the community.
Authors
D. A. Patt
US Oncology, The Woodlands, TX
D. A. Patt , J. L. Espirito , B. Turnwald , J. R. Hoverman , M. A. Neubauer , L. T. Busby , B. D. Brooks , M. A. Kolodziej , R. W. Anderson , R. A. Beveridge
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C
Track
Prevention, Survivorship & Health Policy
Sub Track
Health Services Research
Citation
J Clin Oncol 29, 2011 (suppl 27; abstr 213)
Abstract #
213
Poster Bd #
D3
Abstract Disclosures
Similar Posters
Poster
2015 Breast Cancer Symposium
Review of trends in adjuvant chemotherapy regimens in breast cancer over 10 year period at Yale New Haven Hospital (YNHH).
First Author: Rosana Gnanajothy
Poster
2014 ASCO Annual Meeting
Prophylactic ciprofloxacin to prevent febrile neutropenia in adjuvant breast cancer patients receiving docetaxel (nonanthracycline) regimens.
First Author: Meena Okera
Poster
2012 Breast Cancer Symposium
Adjuvant chemotherapy for early-stage breast cancer: Choice of regimen and associated hematologic toxicities in a metropolitan Australian hospital.
First Author: Katherine Lovat
Poster
2015 ASCO Annual Meeting
Outcomes of adjuvant ACT vs. TC chemotherapy in older women with breast cancer.
First Author: Sarah Schellhorn Mougalian